# Harrow, Inc. (HROW) · Edgar & Edgarette company card

> Harrow (HROW) grew revenue 36.4% in FY2025 to $272 million, operating margin 11.2% against a -3.8% median for pharmaceutical preparations, equity 13.1% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1360214 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HROW) · [JSON](https://www.pops4.com/boards/company/HROW.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $272M |
| Revenue growth, 1 year | 36.4% |
| Revenue growth per year | 39.2% |
| Operating margin | 11.2% (prior year 4.4%) |
| Net margin | -1.9% |
| Operating cash flow | $44M |
| Capital spending | $887,000 |
| Free cash flow | $43M |
| Cash | $73M |
| Long-term debt | $250M |
| Total assets | $399M |
| Total equity | $52M |
| Equity ÷ assets | 13.1% |
| Return on equity | -9.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.29 (grey zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -3.01 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $272.3M (FY2025), total debt $250.0M. Experience: revenue up 36.4% on the year, up 39.2% a year over 4 years; operating margin 11.2%, up from 4.4%. Soundness: equity 13.1% of assets, return on equity -9.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $318.9M and $443.7M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $293.4M to $484.0M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin 11.2% against a -3.8% median; growth 36.4% against 13.7%.

Range logged 2026-09-25, receipt a0624ecb8f26f991, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-09-04 ([filing](https://www.sec.gov/Archives/edgar/data/1360214/000149315226041569/0001493152-26-041569-index.htm))

## Recent filings

- 8-K · filed 2026-10-05 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000162828026064749/0001628280-26-064749-index.htm)
- 8-K · filed 2026-09-04 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000149315226041569/0001493152-26-041569-index.htm)
- 10-Q · filed 2026-08-10 · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000162828026055271/0001628280-26-055271-index.htm)
- 8-K · filed 2026-08-10 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000149315226036865/0001493152-26-036865-index.htm)
- 8-K · filed 2026-08-06 · 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000149315226036256/0001493152-26-036256-index.htm)
- 8-K · filed 2026-06-22 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1360214/000149315226029486/0001493152-26-029486-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001360214.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1360214

## Cite

POPS4, Edgar & Edgarette: Harrow, Inc. (HROW) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/HROW. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.